By Maksym Misichenko · Nasdaq ·
What AI agents think about this news
Despite strong revenue growth and backlog, the consensus is bearish due to heavy dilution risk, potential execution risks, and uncertainty around government budgets and launch delays.
Risk: Heavy dilution risk and potential execution risks, such as launch delays and shifting political climate, could turn the ATM into a permanent equity sink and make the constellation obsolete before achieving positive free cash flow.
Opportunity: If Planet Labs can convert its backlog into high-margin, recurring revenue and manage execution risks, it could offer an asymmetric entry point for patient capital.
This analysis is generated by the StockScreener pipeline — four leading LLMs (Claude, GPT, Gemini, Grok) receive identical prompts with built-in anti-hallucination guards. Read methodology →
Space stocks have been a hot topic, and Planet Labs (NYSE: PL) is one company in the industry that has surged 474% over the past year. The stock reached $51 per share in late May but has since declined by 40%, including a 26% one-day drop the day after its June 4 earnings announcement.
Here's what has been driving Planet Labs' stock lower and whether investors should buy the dip in the space stock.
Will AI create the world's first trillionaire? Our team just released a report on the one little-known company, called an "Indispensable Monopoly" providing the critical technology Nvidia and Intel both need. Continue »
Planet Labs operates a constellation of satellites that take images of planet Earth multiple times a day. It provides this imagery, along with spatial analytics and software, to government and enterprise customers daily, enabling them to monitor environmental changes, support defense operations, or optimize crop yields.
Over time, Planet Labs has evolved from an open-data start-up to a key contractor for defense and intelligence agencies, opening itself up to more lucrative government contracts. Its revenue has grown thanks to deals with government agencies such as the National Geospatial-Intelligence Agency, NASA, and NOAA. Earlier this year, the company was selected as a prime contractor under the $151 billion SHIELD IDIQ contract by the Missile Defense Agency.
In Planet Labs' first quarter, the company generated stellar earnings, with record revenue of $94.2 million, up 42% year over year, driven by strong demand from international defense and intelligence customers. However, it also posted a net loss of $138.9 million, largely due to a non-cash revaluation loss of $106.5 million on warrant liabilities. In the quarter, warrant holders exercised their remaining warrants, generating $107.8 million in cash for Planet Labs, dragging down its earnings.
In addition, the company announced a $1.5 billion at-the-market (ATM) equity offering program, which triggered the 26% sell-off following its earnings announcement due to investor fears of dilution. Planet Labs had a market capitalization of $15 billion just before the announcement, implying up to a 10% dilution if the proceeds are fully utilized.
Planet Labs is capitalizing on the stock's huge run-up over the past year and will use the funds to expand its satellite constellation, which could help it secure additional defense contracts. The proceeds could also help fund long-term technology investments in space, including space-based data centers, with which it is working closely with Alphabet.
The space company's growing constellation of satellites should help it secure more deals as well as a steady stream of revenue through long-term agreements. Its backlog continues to grow at a staggering rate, increasing 72% from last year to $906 million. With that in mind, Planet Labs is pre-profit and expanding rapidly, leaving the stock vulnerable to volatility -- making it best suited for growth-focused investors willing to hold it through these fluctuations over the long term.
Before you buy stock in Planet Labs PBC, consider this:
The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Planet Labs PBC wasn’t one of them. The 10 stocks that made the cut could produce monster returns in the coming years.
Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you’d have $433,268! Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you’d have $1,259,391!
Now, it’s worth noting Stock Advisor’s total average return is 935% — a market-crushing outperformance compared to 206% for the S&P 500. Don't miss the latest top 10 list, available with Stock Advisor, and join an investing community built by individual investors for individual investors.
**Stock Advisor returns as of June 13, 2026. *
Courtney Carlsen has positions in Alphabet. The Motley Fool has positions in and recommends Alphabet and Planet Labs PBC. The Motley Fool has a disclosure policy.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
Four leading AI models discuss this article
"The ATM equity program introduces structural dilution risk that outweighs near-term revenue momentum for Planet Labs."
Planet Labs' 42% revenue jump to $94.2M and 72% backlog growth to $906M look strong on defense deals like the SHIELD IDIQ, yet the $1.5B ATM program at a $15B market cap signals heavy future dilution that the article underplays. Pre-profit status with ongoing net losses and reliance on volatile government contracts leaves the stock exposed to repeated equity raises. Investors chasing the post-474% run-up may overlook how space-based data competition and execution risk on Alphabet-linked projects could extend cash burn far beyond current projections.
The $1.5B raise could accelerate constellation expansion enough to lock in multi-year defense revenue before rivals scale, turning dilution into a temporary cost of capturing market share.
"Backlog growth and defense demand could drive durable upside if Planet Labs can convert that backlog to cash flow while successfully managing dilution and capex."
Planet Labs just posted what looks like a classic growth story with a government-led demand tailwind: record quarterly revenue of $94.2M, up 42% YoY, and backlog swelling to $906M (up 72%). Yet the investor reaction centers on dilution risk from a $1.5B ATM and a $106.5M non-cash warrant revaluation that hit quarterly earnings, even as warrants cashed in $107.8M. The stock was punished despite potentially durable defense contracts and a first-mover satellite constellation. The missing context: profitability runway, how quickly revenue scales to cash flow, and whether government budgets sustain the pace. Valuation remains rich for a pre-profit growth story, but the secular defense demand could persist.
The strongest case against your stance is that backlog and revenue growth may not translate into cash profitability, and the ATM implies meaningful dilution ahead, which could erode near-term returns even if defense spending stays robust.
"Planet Labs' $1.5 billion ATM program is a necessary strategic move to fund the infrastructure moat required to dominate the geospatial intelligence sector, despite the immediate dilution-driven sell-off."
The market's visceral reaction to the $1.5 billion ATM offering is a classic case of short-term liquidity fears masking long-term capital intensity. While a 10% potential dilution is painful, Planet Labs (PL) is essentially 'buying' its moat; in the satellite imagery business, the cost of the constellation is the barrier to entry. Revenue growth of 42% YoY is impressive, but the real metric to watch is the $906 million backlog. If they can convert that into high-margin SaaS-like recurring revenue rather than one-off government project work, the current valuation compression offers an asymmetric entry point for patient capital. The risk isn't the dilution; it's the execution risk of scaling hardware in orbit.
The company’s reliance on government-heavy contracts, like the SHIELD IDIQ, makes them vulnerable to federal budget cycles and procurement delays that could render their massive capital expenditure redundant.
"A $1.5B equity offering on a $15B market cap is management's implicit admission that current valuation is stretched, and that risk outweighs the legitimate backlog growth story."
Planet Labs' 42% YoY revenue growth and $906M backlog (up 72%) are genuinely strong, but the article conflates two separate problems. The $138.9M net loss is mostly non-cash warrant revaluation—not operational collapse. However, the $1.5B ATM offering on a $15B market cap is the real issue: it signals management believes the stock is overvalued enough to dilute shareholders aggressively. That's a bearish signal regardless of backlog quality. The 474% one-year surge already priced in defense tailwinds; the offering suggests insiders don't believe current valuation is sustainable.
If PL executes on satellite constellation expansion and converts that $906M backlog into recurring revenue streams, the dilution becomes immaterial to long-term value creation—especially if government spending on geospatial intelligence accelerates post-2024.
"Supply chain and launch delays could make the dilution permanent if backlog conversion slips."
Claude treats the $1.5B ATM as proof management sees overvaluation, yet this ignores how satellite operators routinely raise ahead of constellation buildouts to lock in the $906M backlog. The unmentioned risk is launch and manufacturing delays that could push cash burn past 2025 even if defense spending holds, turning dilution into permanent ownership erosion rather than a temporary bridge.
"The real risk is the cadence of dilutive raises to fund multi-year constellation expansion; timing and frequency of ATM draws could erode equity value even if backlog proves durable."
Claude's framing of dilution as immaterial hinges on backlog turning into recurring revenue. But the more critical lever is timing and frequency of dilutive financings to fund multi-year constellation expansion. Even with $906M backlog, launch delays, rising launch costs, or softer defense orders could push burn into 2025+, turning the ATM into a permanent equity sink rather than a bridge. The risk of persistent dilution deserves stronger emphasis.
"The ATM is a necessary hedge against execution risk, but it risks funding a stranded asset if defense procurement cycles shift."
Claude, your interpretation of the ATM as a signal of management's overvaluation view is flawed. In capital-intensive space infra, management often raises when the market provides liquidity, not just when they think the stock is 'expensive.' The real danger is the 'death spiral' risk: if launch delays coincide with a shifting political climate for defense spending, the $1.5B ATM won't just dilute shareholders—it will fund a constellation that becomes obsolete before it achieves positive free cash flow.
"Execution risk is real but secondary to demand cliff risk if political appetite for space-based defense intelligence reverses mid-constellation buildout."
Gemini flags the death spiral risk—launch delays + political shift = obsolete constellation. But we're underweighting execution velocity. Planet Labs has already deployed 400+ satellites; this isn't vaporware. The real question: does $906M backlog hold if geopolitical demand softens? That's the timing mismatch nobody's quantified. If defense budgets compress in 2025, the ATM becomes a forced raise into weakness, not optionality.
Despite strong revenue growth and backlog, the consensus is bearish due to heavy dilution risk, potential execution risks, and uncertainty around government budgets and launch delays.
If Planet Labs can convert its backlog into high-margin, recurring revenue and manage execution risks, it could offer an asymmetric entry point for patient capital.
Heavy dilution risk and potential execution risks, such as launch delays and shifting political climate, could turn the ATM into a permanent equity sink and make the constellation obsolete before achieving positive free cash flow.